CLINICAL_TRIALS
trial_result
· 2021-05-04
Clinical Trial Update: Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II Achalasia [Phase 2]
Summary
Phase 2 trial of IW-1701 (an sGC stimulator) in Achalasia was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cyclerion Therapeutics | Conditions: Achalasia | Phase 2 | Status: TERMINATED | Results posted: 2021-05-04